Morbidity risk factors in human cardiac transplantation. Histoincompatibility and protracted graft ischemia entail high risk of rejection and infection

Scand J Thorac Cardiovasc Surg. 1992;26(3):169-76. doi: 10.3109/14017439209099074.

Abstract

Data from the first 103 human heart transplantations performed on 100 recipients (aged 14-62 years) at a single center from November 1983 to January 1990 were analyzed in order to detect morbidity-causing risk factors. Cumulative one- and five-year graft survival was 82% and 68%. Multivariate analysis revealed three independent risk factors for early rejection, viz. HLA-DR and HLA-B mismatches and no prior cardiac surgery. Graft ischemic time exceeding 71 min was an independent risk factor for rejection, especially for moderate or severe events, and for infection. HLA-DR mismatch was an independent risk factor for moderate and severe rejection events and for infections. Finally, patients operated on because of end-stage ischemic heart disease were at significantly higher risk of rejection than those with other cardiac disorders. The study has several implications: Prospective tissue typing for cardiac transplantation and selection of donors may have an impact on graft function: Damage to the graft by prolonged ischemia may be reduced by improved organ preservation.

MeSH terms

  • Adolescent
  • Adult
  • Cohort Studies
  • Cytomegalovirus Infections
  • Female
  • Follow-Up Studies
  • Graft Rejection / etiology*
  • HLA-B Antigens / analysis
  • HLA-DR Antigens / analysis
  • Heart Transplantation / adverse effects*
  • Histocompatibility*
  • Humans
  • Ischemia / physiopathology
  • Male
  • Middle Aged
  • Morbidity
  • Pneumonia, Pneumocystis / etiology
  • Risk Factors
  • Staphylococcal Infections
  • Surgical Wound Infection / etiology*
  • Time Factors

Substances

  • HLA-B Antigens
  • HLA-DR Antigens